MPM BioVentures 2018 GP LLC is 10% Owner at iTeos Therapeutics, Inc. (ITOS). They have made 6 open-market trades across 2 companies since 2021, most recently 2025-05-13.
CIK 0001818701
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 33% | 33% |
| Avg Move | +1.2% | +4.0% | +21.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ITOS | SELL | 2025-05-13 | 2025-05-15 | $8.06 | $10.2M | +27.2% | +27.7% | +27.9% |
| TRDA | SELL | 2024-12-10 | 2024-12-12 | $20.51 | $1.8M | -2.1% | -25.4% | -37.4% |
| ITOS | SELL | 2022-01-04 | 2022-01-06 | $42.58 | $12.5M | -10.8% | -12.6% | -16.8% |
| ITOS | SELL | 2021-10-15 | 2021-10-18 | $27.45 | $939K | -2.7% | +21.8% | +37.4% |
| ITOS | SELL | 2021-10-12 | 2021-10-14 | $27.18 | $2.3M | -3.3% | +9.2% | +46.8% |
| ITOS | SELL | 2021-09-28 | 2021-09-30 | $27.00 | $581K | -1.2% | +3.2% | +70.8% |
| ITOS | SELL · 10b5-1 | 2021-09-23 | 2021-09-27 | $27.76 | $1.5M | -1.7% | +0.4% | +73.5% |
| ITOS | SELL · 10b5-1 | 2021-09-16 | 2021-09-20 | $28.38 | $2.6M | +0.1% | +2.4% | +60.6% |
| ITOS | SELL · 10b5-1 | 2021-09-14 | 2021-09-16 | $27.83 | $772K | -7.5% | -3.1% | +30.9% |
| ITOS | SELL · 10b5-1 | 2021-09-09 | 2021-09-13 | $28.32 | $1.6M | +2.0% | -4.4% | +34.3% |
| ITOS | SELL · 10b5-1 | 2021-04-09 | 2021-04-13 | $29.99 | $4K | -6.0% | -11.9% | -0.4% |
| ITOS | SELL · 10b5-1 | 2021-04-07 | 2021-04-09 | $30.99 | $777K | -11.9% | -16.9% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.